DrugPatentWatch Database Preview

Daiichi Sankyo Inc Company Profile

DAIICHI SANKYO INC has four approved drugs.

There are three US patents protecting DAIICHI SANKYO INC drugs.

There are one hundred and fourteen patent family members on DAIICHI SANKYO INC drugs in thirty-three countries and fourteen supplementary protection certificates in eleven countries.

International Patents:	114
US Patents:	3
Tradenames:	4
Ingredients:	4
NDAs:	4
Patent Litigation for Daiichi Sankyo Inc:	See patent lawsuits for Daiichi Sankyo Inc

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Daiichi Sankyo Inc	ROXYBOND	oxycodone hydrochloride	TABLET;ORAL	209777-002	Apr 20, 2017		DISCN	No	No	7,955,619	➤ Try a Free Trial	Y			➤ Try a Free Trial
Daiichi Sankyo Inc	EVOXAC	cevimeline hydrochloride	CAPSULE;ORAL	020989-002	Jan 11, 2000	AB	RX	Yes	Yes		➤ Try a Free Trial				➤ Try a Free Trial
Daiichi Sankyo Inc	SAVAYSA	edoxaban tosylate	TABLET;ORAL	206316-002	Jan 8, 2015		RX	Yes	No	9,149,532	➤ Try a Free Trial	Y			➤ Try a Free Trial
Daiichi Sankyo Inc	ROXYBOND	oxycodone hydrochloride	TABLET;ORAL	209777-001	Apr 20, 2017		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Daiichi Sankyo Inc	ROXYBOND	oxycodone hydrochloride	TABLET;ORAL	209777-002	Apr 20, 2017		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Daiichi Sankyo Inc	EVOXAC	cevimeline hydrochloride	CAPSULE;ORAL	020989-002	Jan 11, 2000	5,580,880	➤ Try a Free Trial
Daiichi Sankyo Inc	EVOXAC	cevimeline hydrochloride	CAPSULE;ORAL	020989-002	Jan 11, 2000	4,855,290	➤ Try a Free Trial
Daiichi Sankyo Inc	EVOXAC	cevimeline hydrochloride	CAPSULE;ORAL	020989-002	Jan 11, 2000	5,340,821	➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	30 mg	➤ Subscribe	2009-02-27
➤ Subscribe	Tablets	15 mg, 30 mg and 60 mg	➤ Subscribe	2019-01-28
➤ Subscribe	Tablets	15 mg, 30 mg, 60 mg and 100 mg	➤ Subscribe	2019-01-28

Subscribe to access the full database, or try a Free Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1405852	2015/045	Ireland	➤ Try a Free Trial	PRODUCT NAME: EDOXABAN, A SALT THEREOF, A SOLVATIC THEREOF, OR AN N-OXIDE THEREOF, IN PARTICULAR EDOXABAN TOSYLATE; REGISTRATION NO/DATE: EU/1/15/993/001-028 20150619
1685839	92292	Luxembourg	➤ Try a Free Trial	PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
1405852	122015000077	Germany	➤ Try a Free Trial	PRODUCT NAME: EDOXABAN, DESSEN SALZ, DESSEN SOLVAT, ODER DESSEN N-OXID, INSBESONDERE EDOXABANTOSILAT; REGISTRATION NO/DATE: EU/1/15/993/001-028 20150619
2140867	PA2018005	Lithuania	➤ Try a Free Trial	PRODUCT NAME: EDOKSABANAS, JO FARMACINIU POZIURIU PRIIMTINA DRUSKA, ARBA BET KURIO IS JU HIDRATAS, YPAC EDOKSABANO P-TOLUENSULFONATO MONOHIDRATAS; REGISTRATION NO/DATE: EU/1/15/993/001-028 20150619
1405852	C01405852/01	Switzerland	➤ Try a Free Trial	PRODUCT NAME: EDOXABAN; REGISTRATION NO/DATE: SWISSMEDIC 65149 31.03.2015
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.